Can a drug boost brain recovery after stroke?
NCT ID NCT06339411
First seen Aug 10, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This trial tests whether Cerebrolysin, given after a procedure to remove a blood clot from the brain, can reduce tissue damage and improve recovery in people with acute ischemic stroke. The study involves 100 adults aged 18 to 80 who undergo successful clot removal within 6 to 24 hours of stroke onset. Participants receive either Cerebrolysin or a placebo infusion daily for 10 days, and researchers measure brain injury on MRI and track functional recovery over a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cerebrolysin, a drug given by intravenous infusion for 10 days after stroke clot removal
- What this could lead to
- If it works, Cerebrolysin could reduce brain damage and improve recovery after stroke, potentially leading to a new standard of care.
- What could go wrong
- This is an early-phase trial with a modest number of participants, so results may not be conclusive. There is also a risk of side effects like bleeding in the brain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?
- Can a common supplement curb stroke damage?